Clinical laboratory diagnostics and monitoring of ADAMTS13 deficiency and of related diseases: an integrated approach
Nikolaus B. Binder, François Depasse, Michael Spannagl, Jürgen Patzke et autres
0 citationsExpert Review of Hematology
Michael Spannagl
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
207Publications signalées
8598Citations signalées
0Affiliations récentes
Domaines associés
Venous Thromboembolism Diagnosis and ManagementPlatelet Disorders and TreatmentsBlood Coagulation and Thrombosis MechanismsHemophilia Treatment and ResearchAntiplatelet Therapy and Cardiovascular Diseases
Publications récentes
A-391 Analysis of the suitability of the Whole Blood Beads model as control material in glucose point-of-care testing for external quality assessment schemes
Alexander Larbig, Patricia Kaiser, Udo Kramer, Ingo Schellenberg et autres
0 citationsClinical Chemistry
Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseases
Jürgen Patzke, Nikolaus B. Binder, M.R. del Bono, François Depasse et autres
1 citationExpert Review of Hematology
Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
François Depasse, Nikolaus B. Binder, M.R. del Bono, Matthias Germer et autres
3 citationsExpert Review of Hematology
Strengthening international cooperation and confidence in the field of laboratory medicine by ISO standardization
Folker Spitzenberger, Isolde Seiden Long, Michael Spannagl
0 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
Christoph Buchta, Barbara De la Salle, Rachel Marrington, Stéphanie Albarède et autres
19 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles
Christoph Buchta, Rachel Marrington, Barbara De la Salle, Stéphanie Albarède et autres
10 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular
Christoph Buchta, Rachel Marrington, Barbara De la Salle, Stéphanie Albarède et autres
13 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
Christoph Buchta, Rachel Marrington, Barbara De la Salle, Stéphanie Albarède et autres
18 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants
Christoph Buchta, Barbara De la Salle, Rachel Marrington, Andrés Aburto Almonacid et autres
15 citationsClinical Chemistry and Laboratory Medicine (CCLM)
Thrombolytika
0 citationsSpringer Reference Medizin
Revision of the “Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations – Rili-BAEK”
Parviz Ahmad‐Nejad, Walter Bauersfeld, H Baum, Hermann M. Behre et autres
19 citationsJournal of Laboratory Medicine
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.